This study is to compare the safety and efficacy of UHE-105 Shampoo with that of the vehicle (VEH) Shampoo in subjects with scalp psoriasis. Half of the subjects will receive the UHE-105 Shampoo, while the other half will receive the VEH Shampoo with no active drug.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
22
01
San Diego, California, United States
02
High Point, North Carolina, United States
Investigator's Global Assessment (IGA) Treatment Success
The percentage of subjects classified as IGA treatment success
Time frame: Day 15
Investigator's Global Assessment (IGA) Treatment Success
The percentage of subjects classified as IGA treatment success
Time frame: Day 29
Clinical signs of psoriasis (scaling, erythema and plaque elevation) Treatment Success
Percentage of subjects classified as treatment success for each of the clinical signs of psoriasis (scaling, erythema and plaque elevation)
Time frame: Days 8, 15, and 29
Change in Percentage of scalp affected by psoriasis
Change from baseline in the percentage of scalp affected by psoriasis
Time frame: Days 8, 15, and 29
Percentage of subjects with pruritus severity score treatment success
Percentage of subjects classified as treatment success for change from baseline in pruritus severity score using an 11-point numeric rating scale (0-10)
Time frame: Days 8, 15, and 29
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.